Skip to content

A Study Comparing Personalized Homeopathic Treatment vs Gnaphalium Polycephalum for Sciatica Pain Relief

A Randomized Comparative Study To Assess The Effectiveness Of Individualized Homoeopathic Medicine Vis-a-Vis Gnaphalium Polycephalum In The Pain Management In Cases Of Sciatica - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083063
Enrollment
80
Registered
2025-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: GNAPHALIUM POLYCEPHALUM: For patients of sciatica, which covers all the symptoms of medicine will be given Gnaphalium Polycephalum. Medicine shall be given in potencies 30CH, 200CH, 1M

Sponsors

Dr MPK Homoeopathic Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients giving consent for the study Cases of sciatica diagnosed with positive SLRT and/or Slump Test Cases with prominent Xray findings of sciatica Cases of Sciatica with the following symptoms: Constant or intermittent pain anywhere in the the course of the sciatic nerve Sharp, shooting pain anywhere in the course of the sciatic nerve Burning or tingling sensation anywhere in the course of the sciatic nerve

Exclusion criteria

Exclusion criteria: Advanced cases With bladder involvement, Degeneration of spine,Spinal or Intraspinal Tumors, Lumbar canal stenosis, Deformity in the vertebral column Scoliosis, Kyphosis, Lordosis Any lesion of the sciatic nerve (ICD-10 criteria G57.0)12 Any lesion due to intervertebral disc disorder. Immuno-compromised patients such as those suffering from HIV, Hepatitis B or C etc. Pregnant women and lactating mothers will not be included in the study. Cases with multi-systemic illness will be excluded from the study as cases with advanced pathology. Patients who are not willing to give informed consent. Patients taking other treatments for Sciatica.

Design outcomes

Primary

MeasureTime frame
to assess the Effectiveness of Individualised homeopathic medicine vis-a-vis Gnaphalium polycephalum for pain management in cases of sciatica using the VAS Scale.Timepoint: Pre Scores will be taken at the baseline of treatment and post scores will be assessed at the end of 12 weeks using VAS scale

Secondary

MeasureTime frame
To compare the treatment response in cases of Sciatica using the VAS (visual analog scale) Scale treated with individualized homeopathic medicine vis- -vis preidentified homeopathic medicine Gnaphalium polycephalum To assess the extent of improvement in the cases of Sciatica receiving individualized homeopathic medicines To assess the extent of improvement in cases of sciatica receiving preidentified homeopathic medicine Gnaphalium polycephalumTimepoint: 12 months

Countries

India

Contacts

Public ContactDr Rahul Yadav

Dr MPK Homoeopathic Medical College Hospital and Research Centre

PMpg2724dept@gmail.com9983548853

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026